NPCE
Neuropace Inc
14.10$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +11.3% | +9.8% | +0.7% | +43.7% | +22.1% | +25.1% | |
| – | +3.4% | +8.1% | +10.9% | +32.8% | +20.4% | +9.3% | |
| – | +14.4% | +10.4% | -2.8% | +48.1% | +22.8% | +30.7% | |
| – | -14.2% | +16.0% | +20.5% | -5.3% | +13.8% | +17.9% | |
| – | -8.5% | +41.0% | +31.8% | +6.2% | -68.0% | +9.5% | |
| – | -10.7% | +32.0% | +28.2% | +2.7% | +7.3% | +15.9% | |
| – | – | – | – | – | – | – | |
| – | +21.1% | -35.5% | +1.6% | +13.1% | +3.3% | -15.2% | |
| – | – | – | – | – | – | – | |
| – | +8.7% | -82.7% | +209.9% | -77.1% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.